Pub. Date : 2020 Jun
PMID : 32090368
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | CONCLUSIONS: Patients without any CYP2D6 metabolic capacities appear to have increased reduction in DBP, HR, and SBP during metoprolol treatment and may be at a higher risk of bradycardia compared to patients with active CYP2D6 phenotypes. | Metoprolol | selenium binding protein 1 | Homo sapiens |